| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
* Division of Clinical Immunology and Allergy, University of Naples Federico II, and
Division of Hematology, A. Cardarelli Hospital, Naples, Italy;
Institut de Pharmacologie Moléculaire et Cellulaire, Centre National de la Recherche Scientifique, Valbonne, France; and
Departments of Chemistry and Biochemistry, University of Washington, Seattle, WA 98195
Secreted phospholipases A2 (sPLA2) are enzymes released in plasma and extracellular fluids during inflammatory diseases. Because human group IB and X sPLA2s are expressed in the lung, we examined their effects on primary human lung macrophages (HLM). Both sPLA2s induced TNF-
and IL-6 release in a concentration-dependent manner by increasing their mRNA expression. This effect was independent of their enzymatic activity because 1) the capacity of sPLA2s to mobilize arachidonic acid from HLM was unrelated to their ability to induce cytokine production; and 2) two catalytically inactive isoforms of group IB sPLA2 (bromophenacyl bromide-inactivated human sPLA2 and the H48Q mutant of the porcine sPLA2) were as effective as the catalytically active sPLA2s in inducing cytokine production. HLM expressed the M-type receptor for sPLA2s at both mRNA and protein levels, as determined by RT-PCR, immunoblotting, immunoprecipitation, and flow cytometry. Me-indoxam, which decreases sPLA2 activity as well as binding to the M-type receptor, suppressed sPLA2-induced cytokine production. Incubation of HLM with the sPLA2s was associated with phosphorylation of ERK1/2, and a specific inhibitor of this pathway, PD98059, significantly reduced the production of IL-6 elicited by sPLA2s. In conclusion, two distinct sPLA2s produced in the human lung stimulate cytokine production by HLM via a mechanism that is independent of their enzymatic activity and involves activation of the ERK1/2 pathway. HLM express the M-type receptor, but its involvement in eliciting cytokine production deserves further investigation.
This article has been cited by other articles:
|
|
 |
|
  L. H. Beck Jr., R. G.B. Bonegio, G. Lambeau, D. M. Beck, D. W. Powell, T. D. Cummins, J. B. Klein, and D. J. Salant M-Type Phospholipase A2 Receptor as Target Antigen in Idiopathic Membranous Nephropathy N. Engl. J. Med., July 2, 2009; 361(1): 11 - 21. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. P. Hurley and B. A. McCormick Multiple Roles of Phospholipase A2 during Lung Infection and Inflammation Infect. Immun., June 1, 2008; 76(6): 2259 - 2272. [Full Text] [PDF]
|
|
|
|
 |
|
 N L A Misso, N Petrovic, C Grove, A Celenza, J Brooks-Wildhaber, and P J Thompson Plasma phospholipase A2 activity in patients with asthma: association with body mass index and cholesterol concentration Thorax, January 1, 2008; 63(1): 21 - 26. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S.-A. Karabina, I. Brocheriou, G. Le Naour, M. Agrapart, H. Durand, M. Gelb, G. Lambeau, and E. Ninio Atherogenic properties of LDL particles modified by human group X secreted phospholipase A2 on human endothelial cell function FASEB J, December 1, 2006; 20(14): 2547 - 2549. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Guillaume, C. Calzada, M. Lagarde, J. Schrevel, and C. Deregnaucourt Interplay between lipoproteins and bee venom phospholipase A2 in relation to their anti-plasmodium toxicity J. Lipid Res., July 1, 2006; 47(7): 1493 - 1506. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. A. Moura, H. Koc, D. A. Chapman, and G. J. Killian Identification of Proteins in the Accessory Sex Gland Fluid Associated With Fertility Indexes of Dairy Bulls: A Proteomic Approach J Androl, March 1, 2006; 27(2): 201 - 211. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
